BRIEF-Telesta Therapeutics says type A meeting has been scheduled with U.S. FDA
April 12 (Reuters) - Telesta Therapeutics Inc
* Says type a meeting has been scheduled with u.s. Food and drug administration (fda) on friday, april 15 , 2016
* Type a meeting will be focused on fda's responses to telesta's questions concerning approval of mcna 1 in united states Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.